Compounds > platinum
Page last updated: 2024-08-22

platinum and Breast Neoplasms

platinum has been researched along with Breast Neoplasms in 111 studies

Research

Studies (111)

TimeframeStudies, this research(%)All Research%
pre-19906 (5.41)18.7374
1990's14 (12.61)18.2507
2000's8 (7.21)29.6817
2010's36 (32.43)24.3611
2020's47 (42.34)2.80

Authors

AuthorsStudies
Chua, YJ; Noguchi, E; Shimoi, T; Sudo, K; Yonemori, K1
Shimanuki, Y; Shimizu, C; Shimomura, A; Terakado, H; Yoshimura, K1
Lin, H; Liu, HK; Su, Y; Su, Z; Tu, Y; Wang, MM; Yang, J; Zhang, GD1
Connell, PP; Li, X; Liang, X; Liu, S; Sun, X; Yang, W; Yuan, X; Zuo, K1
Jevtić, VV; Matić, MM; Obradović, AD; Ognjanović, BI; Paunović, MG; Stojković, DL1
Eichhorn, T; Hey-Hawkins, E; Kaluđerović, GN; Morgan, I; Predarska, I; Saoud, M1
Hou, Y; Liu, X; Su, R; Xu, J; Yang, T; Zhao, M1
Han, SB; He, Y; Liu, Y; Wu, YM; Zhang, JJ1
Cabel, L; Caron, O; de La Motte Rouge, T; Delaloge, S; Desmoulins, I; Filleron, T; Frenel, JS; Jacot, W; Levy, C; Lusque, A; Mailliez, A; Patsouris, A; Robain, M; Thery, JC; Tredan, O; Uwer, L; Vicier, C1
Cheng, MY; Gao, HF; Ji, F; Li, JQ; Lin, YY; Wang, K; Yang, CQ; Yang, M; Yang, X; Zhang, LL; Zheng, XX; Zhu, T1
Chen, X; Dong, S; Hou, D; Li, H; Peng, Y; Wang, H1
Chen, Q; Chen, Y; Guo, J; Li, X; Lin, J; Lin, M; Lin, W; Weng, Y; Yu, X; Zeng, S; Zheng, X1
Dong, Q; Du, F; Gao, L; Huo, X; Li, Z; Liu, Z; Ren, D; Shen, G; Wang, M; Xie, Q; Xin, Y; Zhao, F; Zhao, J; Zhao, Y1
Banerjee, S; Birrer, M; Drapkin, R; Richardson, DL1
Charmi, J; Ertas, YN; Ghaffarlou, M; Nosrati, H; Rashidzadeh, H; Salehiabar, M; Seidi, F; Yaray, K1
Belleville, E; Brucker, SY; Erber, R; Fasching, PA; Fehm, TN; Häberle, L; Hack, CC; Hartkopf, AD; Hartmann, A; Hein, A; Janni, W; Kolberg, HC; Rübner, M; Theuser, AK; Uhrig, S; Untch, M1
Bezgodova, N; Cherdyntseva, N; Denisov, E; Iamshchikov, P; Ibragimova, M; Kazakova, E; Kiselev, A; Koshkin, P; Kzhyshkowska, J; Larionova, I; Litviakov, N; Liu, Q; Liu, T; Mossel, DM; Patysheva, M; Pyankov, D; Rakina, M; Riabov, V; Sergushichev, A; Tsyganov, M; Vtorushin, S1
Amereh, M; Barsbay, M; Charmi, J; Ghaffarlou, M; Javani, S; Nosrati, H; Salehiabar, M; Seidi, F; Sharafi, A; Yousefnejad, S1
Berardi, R; Boscolo Bielo, L; Cortesi, L; Curigliano, G; Del Mastro, L; Favero, D; Gandini, S; Giarratano, T; Guarneri, V; Lambertini, M; Marra, A; Moscetti, L; Pistelli, M; Sposetti, C; Trapani, D; Valenza, C; Vernieri, C; Zambelli, A1
Azadi, Y; Behzad, M; Eslami Moghadam, M; Hasanzadeh Esfahani, M; Ramezani, N; Zolghadri, S1
Cai, L; Chen, H; Guo, Z; Tan, Y; Wang, X; Wang, Y; Yang, T; Zhang, S1
Bu, H; Feng, S; Huang, Y; Jin, C; Kong, B; Li, N; Liu, J; Ma, Y; Song, K; Wen, H; Wu, L; Yang, X; Zhang, H1
Abraham, DT; Backianathan, S; Balakrishnan, R; Chacko, RT; Cherian, AJ; George, TK; Georgy, JT; Joel, A; John, AO; Manipadam, MT; Patole, S; Paul, MJ; Ramnath, N; Rebekah, G; Sebastian, P; Sharma, P; Sigamani, E; Singh, A; Thumaty, DB1
Alma, MH; Altunoglu, YC; Atalar, MN; Aygun, A; Baloglu, MC; Gülbagca, F; Ozer, LY; Sen, F; Ustaoglu, B1
Chi, K; Sun, Y; Wang, S; Xiao, F; Xiao, J; Xu, Y; Zhang, Y; Zhao, A1
Bi, YY; Chang, X; Jiang, HL; Xing, L; Yang, CX; Yu, ZQ; Zhang, ZQ; Zhou, TJ1
Joung, EK; Lee, J; Oh, S; Park, SJ; Yang, JH1
Dang, M; Fu, B; Li, Y; Tang, Y; Tao, J1
Barbanente, A; Esposti, LD; Iafisco, M; Leeuwenburgh, SCG; Margiotta, N; Nadar, RA; Palazzo, B; van den Beucken, JJJP1
Adalsteinsson, VA; Buendia Buendia, J; Cohen, O; D'Andrea, AD; Dunn, CE; Freeman, SS; Geradts, J; Helvie, K; Hughes, ME; Isakoff, S; Ivy, SP; Kim, D; Kochupurakkal, B; Krop, IE; Lin, NU; Lloyd, MR; LoRusso, P; Marini, L; Matulonis, U; Shapiro, GI; Tolaney, SM; Wagle, N; Waks, AG; Wander, S; Winer, EP1
Chen, H; Chen, S; Ding, F; Song, H; Xiao, H; Zhang, L1
Asokan, N; Barbanente, A; Bornhäuser, M; Brand, M; Curci, A; Degli Esposti, L; Iafisco, M; Karst, U; Leeuwenburgh, SCG; Margiotta, N; Nadar, RA; Schlatt, L; van den Beucken, JJJP1
Bielawska, A; Bielawski, K; Czarnomysy, R; Hermanowicz, JM; Muszyńska, A; Prokop, I; Radomska, D1
Chen, Q; He, D; Shen, Y; Sun, C; Tu, J; Wang, H; Wang, J; Wang, R; Xiong, Y; Yu, Y1
Brabec, V; Kasparkova, J; Kostrhunova, H; Markova, L; Zajac, J1
Telli, ML1
Cao, XZ; Feng, Y; Li, ZY; Ren, SS; Zhang, Z1
Alcaraz-Sanabria, A; Burgos, M; Corrales-Sanchez, V; Galan-Moya, EM; Martinez-Canales, S; Montero, JC; Nieto-Jimenez, C; Nuncia-Cantarero, M; Ocaña, A; Pandiella, A1
Behzad, M; Eslami Moghadam, M; Ramezani, N; Zolghadri, S1
Bi, YY; Huang, ZJ; Jiang, HL; Li, F; Li, L; Shen, LJ; Wei, Q; Xing, L; Yang, CX; Zhao, D; Zhou, TJ1
Awada, A; de Azambuja, E; Eiger, D; Ferreira, SC; Franzoi, MA; Saúde-Conde, R1
Chen, HZ; Dong, X; Fang, C; Feng, HY; Gao, Y; Lai, X; Liu, HJ; Liu, XL; Lovell, JF; Lu, Q; Yang, SC; Yuan, Y; Zhu, MH1
Bilewicz, A; Chajduk, E; Gaweł, D; Majkowska-Pilip, A; Pieńkowski, T; Wawrowicz, K1
Bourneuf, E; Chevillard, S; Grall, R; Hullo, M; Lacombe, S; Mathé, C; Ménard, V; Perrot, Y; Porcel, E; Villagrasa, C; Yang, X1
Bielawski, K; Czarnomysy, R; Muszyńska, A; Rok, J; Rzepka, Z1
Cortes-Bullich, A; Gonzalez-Perez, A; Lopez-Bigas, N; Muiños, F; Pich, O; Pratcorona, M1
Chan, MCW; Chen, C; Chen, D; Chen, H; Guo, Z; He, X; Li, J; Li, L; Rao, J; Yang, L; Zhang, LW; Zou, Y1
Avan, A; Beheshti, F; Ferns, GA; Hasanzadeh, M; Hassanian, SM; Hosseini, M; Khazaei, M; Maftouh, M; ShahidSales, S1
Chan, L; Chen, T; Du, Y; Zhou, B; Zhu, H1
Guo, Z; Luo, C; Muhammad, N; Sadia, N; Wang, X; Zhu, C1
Lang, JH; Ren, T; Shen, K; Sun, J; Sun, TT; Wang, S; Xiang, Y1
de Vere White, R; Henderson, PT; Malfatti, MA; Pan, CX; Scharadin, TM; Turteltaub, KW; Wang, S; Zimmermann, M1
Balmaña, J; Chappey, C; Ettl, J; Fasching, PA; Grischke, EM; Hannah, AL; Hurvitz, SA; Mailliez, A; Mina, LA; Robson, ME; Rugo, HS; Telli, ML; Turner, NC; Wardley, AM1
Chen, NT; Cheng, SH; Chu, CH; Liao, WN; Lo, LW1
Cao, W; Chen, J; Chen, X; Ge, L; Ling, X; Ma, M; Tan, J; Wu, J; Xiong, F1
Bernards, R; Bouwman, P; Brambillasca, C; Büttner, R; Caldas, C; Eichler, C; Hahnen, E; Hauptmann, M; Jonkers, J; Jóźwiak, K; Linn, S; Lips, E; Mallmann, P; Malter, W; Opdam, M; Ozretić, L; Pandey, GK; Puppe, J; Reinhardt, HC; Rhiem, K; Schmutzler, R; Schömig-Markiefka, B; Schouten, PC; Severson, T; Thangarajah, F; van de Ven, M; van Lohuizen, M; van Tellingen, O; Wesseling, J1
Eskandari, A; Ghosh, S; Kundu, A; Suntharalingam, K1
Han, R; Liu, Q; Peng, J; Qian, Z; Shi, K; Wei, X; Xiao, Y; Yang, Q1
Chae, A; Jang, H; Kang, K; Kang, S; Kim, YK; Min, DH1
Bierbach, U; Ding, S; Kucera, GL; Qiao, X1
Andersson, S; Marques, MP; Oredsson, S; Persson, L; Silva, TM; Sukumaran, SK1
Kim, MI; Lee, J; Park, HG; Woo, MA; Ye, Y1
Liu, F; Lu, J; Song, X; Sun, G; Yan, M; Yu, J1
Kang, KS; Kim, MI; Kim, MS; Lee, J; Park, HG; Woo, MA; Ye, Y1
Cossa, LG; De Pascali, SA; Fanizzi, FP; Marsigliante, S; Migoni, D; Muscella, A; Vetrugno, C1
Ge, S; Liu, F; Song, X; Yan, M; Yu, J1
Ahamed, M; Akhtar, MJ; Alhadlaq, HA; Alrokayan, SA; Khan, MA1
Das, A; Gill, MR; Jarman, PJ; Ramu, V; Smythe, C; Thomas, JA; Turton, D1
Ali, M; Crawford, J; Gabrail, N; Glaspy, JA; Goldschmidt, J; Hesketh, PJ; Laadem, A; Osborne, C; Puccio-Pick, M; Raftopoulos, H; Sherman, ML; Wang, D; Zou, J1
Divsalar, A; Eslami Moghadam, M; Kantoury, M; Tarlani, AA1
Abedi, A; Amani, V; Bozorgmehr, M; Lighvan, ZM; Mirzadegan, E; Mohammadi, F; Safari, N; Shahsavar, F; Zarnani, AH1
Beck, SL; Brown, S; Kolb, NA; Mooney, K; Singleton, JR; Smith, AG; Stoddard, GJ1
Li, Y; Qi, W; Song, Y; Wang, Y; Zhu, G1
Bernhardy, AJ; Cai, KQ; George, E; Harrell, MI; Johnson, N; Kim, HH; Krais, JJ; Nicolas, E; Simpkins, F; Swisher, EM; Wang, Y1
Bernish, BW; Bierbach, U; Ding, S; Donati, GL; Fahrenholtz, CD; Gross, MD; Singh, R; Wright, ML; Yang, M; Yao, X; Zheng, Y1
Sharma, P1
Asselin, E; Bélanger, G; Bérubé, G; Descôteaux, C; Leblanc, V; Parent, S1
Allan, S; Bajdik, C; Chia, S; Gelmon, KA; Hassell, P; Hayes, MM; Norris, B; O'Reilly, SE; Shenkier, TN; Speers, C; Yerushalmi, R1
Bielawska, A; Bielawski, K; Czarnomysy, R; Popławska, B; Surazyński, A1
Di Leo, A; Oakman, C; Viale, G1
Bull, JM; Chan, D; Deng, W; He, G; Proett, JM; Rowe, RW; Siddik, Z; Strebel, FR1
Kajiura, Y; Yagata, H; Yamauchi, H1
Foretová, L; Fridrichová, P; Laco, J; Melichar, B; Papajík, T; Simkovič, M1
Eckstein, N; Haas, B1
Fandzloch, M; Muzioł, T; Sitkowski, J; Wietrzyk, J; Łakomska, I1
Couzin, J1
Asselin, E; Bérubé, G; Bridson, J; Church, JG; Mandal, S; Mandal, SK; Pham, TN; Pramanik, SK; Richardson, VJ1
Schwarz, MA; Snyder, RD1
Culo, F; Spellman, JM; Yuhas, JM1
Guo, JH; Song, ST; Xu, ZL1
Alonso, C; González, VM; Masaguer, JR; Navarro-Ranninger, C; Ochoa, PA; Pérez, JM1
Akman, S; Doroshow, JH; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Newman, E; Raschko, J; Somlo, G; Womack, E1
Allain, P; Buquet-Fagot, C; Cvitkovic, E; Djelloul, S; Gespach, C; Louvet, C; Mester, J; Raymond, E1
Bird, RE; DeAngelis, GA; Fajardo, LL; Herman, CR1
Bernhardt, G; Gust, R; Hummel, E; Koch, M; Krauser, R; Schmid, B; Schnurr, B; Schönenberger, H1
Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E1
Davis, J; Hannon, MJ; Jackson, A; Pither, RJ; Rodger, A1
Bedenne, L; Cercueil, JP; Chauffert, B; Correia, M; Coudert, B; Fargeot, P; Flesch, M; Isambert, N; Krause, D; Osmak, L; Zanetta, S1
Bull, JM; Cysyk, R; Gormley, PE; LeRoy, AF1
Bernhardt, G; Hollstein, M; Koch, M; Lux, F; Reile, H; Schönenberger, H1
Guo, JH1
Zhang, M1
Amemiya, Y; Hattori, K; Kida, Y; Kobayashi, T; Matsui, M; Tanaka, T1
Egorin, MJ; Haraf, DJ; Mick, R; Moormeier, JA; Ratain, MJ; Vokes, EE; Weichselbaum, RR1
Brann, TW; Frei, E; Herman, TS; Holden, SA; Khandekar, V; Korbut, TT; Rosbe, KW; Sotomayor, EA; Teicher, BA1
Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M1
el-Yazigi, A; Kanaan, I; Martin, CR; Siqueira, EB1
Ikeda, T; Ishikura, T; Itaoka, T; Nakajima, H; Nitta, S; Yokoyama, M1
Adenis, L; Bonneterre, J; Caty, A; Demaille, A; Fournier, C; Hecquet, B; Lefebvre, JL; Vennin, P1
Dohnalová, J; Dostálová, O; Drobník, J; Fiserová, J; Holík, F1

Reviews

9 review(s) available for platinum and Breast Neoplasms

ArticleYear
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis.
    Breast (Edinburgh, Scotland), 2022, Volume: 66

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Neoadjuvant Therapy; Network Meta-Analysis; Platinum; Taxoids; Triple Negative Breast Neoplasms

2022
Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis.
    Clinical and experimental medicine, 2023, Volume: 23, Issue:6

    Topics: Anemia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Breast Neoplasms; Female; Humans; Myalgia; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Platinum; Prognosis; Triple Negative Breast Neoplasms

2023
Targeting NaPi2b in ovarian cancer.
    Cancer treatment reviews, 2023, Volume: 112

    Topics: Biomarkers; Breast Neoplasms; Female; Humans; Immunoconjugates; Immunohistochemistry; Ovarian Neoplasms; Platinum

2023
Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis.
    The Journal of international medical research, 2020, Volume: 48, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Humans; Neoadjuvant Therapy; Platinum; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome; Triple Negative Breast Neoplasms

2020
Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.
    Journal of cellular physiology, 2018, Volume: 233, Issue:4

    Topics: Antineoplastic Agents; Breast Neoplasms; DNA Repair; Drug Resistance, Neoplasm; Female; Genetic Variation; Humans; Platinum

2018
Management of triple negative breast cancer.
    Breast (Edinburgh, Scotland), 2010, Volume: 19, Issue:5

    Topics: Angiogenesis Inhibitors; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Epothilones; ErbB Receptors; Female; Gene Expression Profiling; Genes, BRCA1; Humans; Immunohistochemistry; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Receptors, TNF-Related Apoptosis-Inducing Ligand; Taxoids

2010
Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
    Breast cancer (Tokyo, Japan), 2011, Volume: 18, Issue:3

    Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Receptors, Estrogen; Taxoids

2011
[Platinum-based chemotherapy in triple negative breast cancer].
    Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Platinum

2012
Fluorouracil and leucovorin in advanced breast cancer.
    Advances in experimental medicine and biology, 1993, Volume: 339

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorouracil; Humans; Leucovorin; Platinum

1993

Trials

7 trial(s) available for platinum and Breast Neoplasms

ArticleYear
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
    British journal of cancer, 2022, Volume: 127, Issue:11

    Topics: Antineoplastic Agents; BRCA1 Protein; Breast Neoplasms; Female; Germ Cells; Humans; Mutation; Platinum

2022
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041).
    European journal of cancer (Oxford, England : 1990), 2023, Volume: 184

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Humans; Neoadjuvant Therapy; Paclitaxel; Platinum; Prospective Studies; Quality of Life; Treatment Outcome; Triple Negative Breast Neoplasms

2023
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 05-01, Volume: 25, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Cohort Studies; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Germ-Line Mutation; Humans; Middle Aged; Neoplasm Metastasis; Phthalazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Prognosis; Salvage Therapy

2019
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:4

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method; Female; Humans; Induction Chemotherapy; Middle Aged; Platinum; Recombinant Fusion Proteins

2016
A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers.
    Clinical breast cancer, 2009, Volume: 9, Issue:3

    Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Platinum; Treatment Outcome

2009
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
    Journal of experimental & clinical cancer research : CR, 2001, Volume: 20, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Balloon Occlusion; Breast Neoplasms; Cell Survival; Cisplatin; Colorectal Neoplasms; Female; Glucose; Hepatic Artery; Humans; Hypotonic Solutions; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Pilot Projects; Platinum; Tumor Cells, Cultured

2001
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Leucovorin; Lung Neoplasms; Male; Middle Aged; Platinum

1992

Other Studies

95 other study(ies) available for platinum and Breast Neoplasms

ArticleYear
Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 11-01, Volume: 39, Issue:31

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Platinum; Triple Negative Breast Neoplasms

2021
Are Platinum Drugs Ineffective for Triple-Negative Breast Cancer With Residual Invasive Disease After Neoadjuvant Chemotherapy?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 11-01, Volume: 39, Issue:31

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Neoadjuvant Therapy; Pharmaceutical Preparations; Platinum; Triple Negative Breast Neoplasms

2021
Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.
    Journal of inorganic biochemistry, 2022, Volume: 226

    Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Coordination Complexes; Drug Delivery Systems; Female; Hep G2 Cells; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Platinum; Prodrugs

2022
qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer.
    Breast cancer research and treatment, 2022, Volume: 191, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; DNA; Female; Homologous Recombination; Humans; Neoadjuvant Therapy; Platinum; Retrospective Studies; Triple Negative Breast Neoplasms

2022
Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines.
    Drug development research, 2022, Volume: 83, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Choriocarcinoma; Cisplatin; Female; Humans; Platinum; Resveratrol

2022
Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
    Dalton transactions (Cambridge, England : 2003), 2022, Jan-17, Volume: 51, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Humans; Ibuprofen; Molecular Structure; Naproxen; Platinum; Silicon Dioxide

2022
Combination of Electrochemistry and Mass Spectrometry to Study Nitric Oxide Metabolism and Its Modulation by Compound K in Breast Cancer Cells.
    Analytical chemistry, 2022, 03-29, Volume: 94, Issue:12

    Topics: Arginine; Breast Neoplasms; Electrochemistry; Female; Ginsenosides; Humans; Metal Nanoparticles; Nitric Oxide; Pharmaceutical Preparations; Platinum; Tandem Mass Spectrometry

2022
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
    BMC cancer, 2022, Apr-14, Volume: 22, Issue:1

    Topics: Apolipoprotein A-I; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Phosphatidylinositol 3-Kinases; Platinum; Uterine Cervical Neoplasms

2022
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1.
    Cells, 2022, 10-21, Volume: 11, Issue:20

    Topics: Adenosine Diphosphate Ribose; Breast Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Membrane Proteins; Microtubule-Associated Proteins; Microtubules; Platinum; Prognosis; Tumor Microenvironment

2022
Optimal exposure to docetaxel in adjuvant chemotherapy for early-stage breast cancer.
    Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Female; Hemoglobins; Humans; Neutropenia; Platinum; Taxoids

2022
Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor.
    International journal of biological macromolecules, 2023, Apr-01, Volume: 233

    Topics: Alginates; Animals; Breast Neoplasms; Female; Humans; Mammary Neoplasms, Animal; Metal Nanoparticles; Nanoparticles; Platinum; Radiation-Sensitizing Agents; Spectroscopy, Fourier Transform Infrared

2023
Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Animals; Breast Neoplasms; Carrier Proteins; Cisplatin; Cricetinae; Cricetulus; Epidermal Growth Factor; Female; Humans; Macrophages; Platinum; Synaptotagmins; Tumor Microenvironment; Tumor-Associated Macrophages

2023
Synthesis of Pt nanoparticles with gelatin-assisted green route to improve sensitization of cancer cells to X-Ray irradiation.
    International journal of pharmaceutics, 2023, Aug-25, Volume: 643

    Topics: Breast Neoplasms; Endothelial Cells; Female; Gelatin; Humans; Metal Nanoparticles; Nanoparticles; Platinum; Radiation-Sensitizing Agents; Reactive Oxygen Species; X-Rays

2023
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments.
    European journal of cancer (Oxford, England : 1990), 2023, Volume: 190

    Topics: BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Female; Germ Cells; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Retrospective Studies

2023
New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2023, Volume: 28, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Coordination Complexes; DNA; Female; Humans; Ligands; Molecular Docking Simulation; Platinum; Schiff Bases; Spectroscopy, Fourier Transform Infrared; X-Rays

2023
Platinum(IV) Complexes as Inhibitors of STAT3 and Regulators of the Tumor Microenvironment To Control Breast Cancer.
    Journal of medicinal chemistry, 2023, 08-24, Volume: 66, Issue:16

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Platinum; STAT3 Transcription Factor; Tumor Microenvironment

2023
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse.
    Journal of ovarian research, 2023, Oct-28, Volume: 16, Issue:1

    Topics: BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Disease Progression; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Recurrence; Retrospective Studies; Ribose

2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer.
    Cancer investigation, 2023, Volume: 41, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Neoadjuvant Therapy; Platinum; Taxoids; Treatment Outcome; Triple Negative Breast Neoplasms

2023
Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent.
    Journal of pharmaceutical and biomedical analysis, 2020, Feb-05, Volume: 179

    Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Inhibitory Concentration 50; Metal Nanoparticles; Nigella sativa; Plant Extracts; Platinum; Seeds; Uterine Cervical Neoplasms

2020
Coral-like hierarchical structured carbon nanoscaffold with improved sensitivity for biomolecular detection in cancer tissue.
    Biosensors & bioelectronics, 2020, Feb-15, Volume: 150

    Topics: Animals; Biosensing Techniques; Breast Neoplasms; Carbon; Carbon Fiber; Cell Line, Tumor; Electroplating; Female; Humans; Hydrogen Peroxide; Metal Nanoparticles; Mice; Microelectrodes; Nanostructures; Nanotubes, Carbon; Oxidation-Reduction; Platinum

2020
Synergistic Platinum(II) Prodrug Nanoparticles for Enhanced Breast Cancer Therapy.
    Molecular pharmaceutics, 2020, 04-06, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Delivery Systems; Female; Mice; Mice, Inbred BALB C; Nanoparticles; Platinum; Prodrugs

2020
Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer.
    The Korean journal of internal medicine, 2021, Volume: 36, Issue:1

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Female; Humans; Maintenance Chemotherapy; Platinum; Retrospective Studies; Taxoids; Treatment Outcome

2021
Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy.
    Journal of colloid and interface science, 2020, Jun-15, Volume: 570

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Metal Nanoparticles; Particle Size; Photochemotherapy; Platinum; Porosity; Surface Properties

2020
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells.
    Journal of materials chemistry. B, 2020, 04-08, Volume: 8, Issue:14

    Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Coculture Techniques; Drug Liberation; Drug Screening Assays, Antitumor; Durapatite; Humans; Kinetics; Male; Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Selenium; Stem Cells; Surface Properties; Tumor Cells, Cultured

2020
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2020, Volume: 31, Issue:5

    Topics: BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2020
Enhancing the chemotherapeutic efficacy of platinum prodrug nanoparticles and inhibiting cancer metastasis by targeting iron homeostasis.
    Nanoscale horizons, 2020, 06-02, Volume: 5, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Coordination Complexes; Drug Carriers; Drug Combinations; Female; Homeostasis; Humans; Iron; Iron Chelating Agents; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Platinum; Prodrugs; Thiosemicarbazones; Xenograft Model Antitumor Assays

2020
Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model.
    Nanoscale, 2020, Jul-02, Volume: 12, Issue:25

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Durapatite; Heterografts; Humans; Nanoparticles; Platinum; Xenograft Model Antitumor Assays; Zebrafish

2020
Evaluation of the Anticancer Activities of Novel Transition Metal Complexes with Berenil and Nitroimidazole.
    Molecules (Basel, Switzerland), 2020, Jun-21, Volume: 25, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagosomes; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Coordination Complexes; Diminazene; DNA; DNA Topoisomerases, Type II; Female; Gold; Humans; Membrane Potential, Mitochondrial; Mitochondria; Nitroimidazoles; Organometallic Compounds; Palladium; Platinum; Transition Elements; Xenograft Model Antitumor Assays; Zebrafish

2020
Redox-sensitive polyglutamic acid-platinum(IV) prodrug grafted nanoconjugates for efficient delivery of cisplatin into breast tumor.
    Nanomedicine : nanotechnology, biology, and medicine, 2020, Volume: 29

    Topics: Animals; Breast Neoplasms; Cisplatin; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Mice; Nanoconjugates; Oxidation-Reduction; Platinum; Polyglutamic Acid; Prodrugs; Xenograft Model Antitumor Assays

2020
A Multi-action Pt
    Angewandte Chemie (International ed. in English), 2020, 11-16, Volume: 59, Issue:47

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cinnamates; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Molecular Structure; Oleic Acid; Platinum; Receptor, ErbB-2

2020
BROCADE3: a challenge to the treatment paradigm in BRCA breast cancer?
    The Lancet. Oncology, 2020, Volume: 21, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Genes, BRCA1; Genes, BRCA2; Germ-Line Mutation; Humans; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Treatment Outcome

2020
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
    International journal of molecular sciences, 2020, Nov-27, Volume: 21, Issue:23

    Topics: Apoptosis; Breast Neoplasms; Carboplatin; Caspases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Cisplatin; Deoxycytidine; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Humans; Neoplasm Invasiveness; Platinum

2020
Two new oral candidates as anticancer platinum complexes of 1,3-dimethyl pentyl glycine ligand as doping agents against breast cancer.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2021, Apr-15, Volume: 251

    Topics: Antineoplastic Agents; Breast Neoplasms; Doping in Sports; Glycine; Humans; Ligands; Platinum

2021
A carrier-free anti-inflammatory platinum (II) self-delivered nanoprodrug for enhanced breast cancer therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2021, 03-10, Volume: 331

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Female; Humans; Nanoparticles; Platinum

2021
[Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version)].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2021, Feb-23, Volume: 43, Issue:2

    Topics: Breast Neoplasms; Consensus; Female; Humans; Platinum

2021
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.
    Breast (Edinburgh, Scotland), 2021, Volume: 57

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Middle Aged; Platinum; Prognosis; Receptor, ErbB-2; Retrospective Studies; Superior Vena Cava Syndrome; Survival Rate; Treatment Outcome; Triple Negative Breast Neoplasms

2021
Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:8

    Topics: Animals; Biomimetics; Breast Neoplasms; Female; Liposomes; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Photochemotherapy; Photosensitizing Agents; Platinum

2021
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of
    Molecules (Basel, Switzerland), 2021, Apr-03, Volume: 26, Issue:7

    Topics: Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Electrons; Female; Gold; Humans; Hydrodynamics; Imaging, Three-Dimensional; Liver Neoplasms; Metal Nanoparticles; Particle Size; Platinum; Polyethylene Glycols; Radioisotopes; Receptor, ErbB-2; Static Electricity; Trastuzumab

2021
Radiation Enhancer Effect of Platinum Nanoparticles in Breast Cancer Cell Lines: In Vitro and In Silico Analyses.
    International journal of molecular sciences, 2021, Apr-23, Volume: 22, Issue:9

    Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Computer Simulation; Female; Humans; In Vitro Techniques; Metal Nanoparticles; Oxidative Stress; Platinum; Radiation-Sensitizing Agents; Radiation, Ionizing; Tumor Cells, Cultured

2021
Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer Cells.
    International journal of molecular sciences, 2021, May-25, Volume: 22, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Coordination Complexes; Dendrimers; Female; Humans; Imidazoles; MAP Kinase Signaling System; MCF-7 Cells; Neoplasm Proteins; Platinum

2021
The evolution of hematopoietic cells under cancer therapy.
    Nature communications, 2021, 08-10, Volume: 12, Issue:1

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clonal Evolution; Clone Cells; Cohort Studies; Female; Fluorouracil; Hematopoiesis; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid; Mutagenesis; Mutation; Neoplasms, Second Primary; Platinum; Tumor Suppressor Protein p53

2021
Mitochondria-targeted platinum(ii) complexes: dual inhibitory activities on tumor cell proliferation and migration/invasion via intracellular trafficking of β-catenin.
    Metallomics : integrated biometal science, 2017, 06-21, Volume: 9, Issue:6

    Topics: A549 Cells; Animals; Antineoplastic Agents; beta Catenin; Breast Neoplasms; Cell Adhesion; Cell Movement; Cell Proliferation; Female; Hep G2 Cells; Humans; Mice; Mitochondria; Neoplasm Invasiveness; Platinum; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017
Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Drug Delivery Systems; Female; Graphite; Humans; MCF-7 Cells; Nanostructures; Oxides; Platinum; Platinum Compounds; Reactive Oxygen Species; Transferrin

2017
Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells.
    Chemical communications (Cambridge, England), 2017, Sep-05, Volume: 53, Issue:72

    Topics: Animals; Antineoplastic Agents; Biotin; Breast Neoplasms; Cattle; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; Epithelial Cells; Female; Humans; Oxidation-Reduction; Platinum

2017
Clinical analysis of chemo-resistance risk factors in endometriosis associated ovarian cancer.
    Journal of ovarian research, 2018, May-29, Volume: 11, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; CA-125 Antigen; Cytoreduction Surgical Procedures; Drug Resistance, Neoplasm; Endometriosis; Female; Humans; Membrane Proteins; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platinum; Risk Factors

2018
Correlation of Platinum Cytotoxicity to Drug-DNA Adduct Levels in a Breast Cancer Cell Line Panel.
    Chemical research in toxicology, 2018, 12-17, Volume: 31, Issue:12

    Topics: Breast Neoplasms; Carboplatin; Cell Line, Tumor; Coordination Complexes; DNA Adducts; DNA Damage; DNA Repair; Female; Humans; Mass Spectrometry; Oxaliplatin; Platinum

2018
Microwave-Synthesized Platinum-Embedded Mesoporous Silica Nanoparticles as Dual-Modality Contrast Agents: Computed Tomography and Optical Imaging.
    International journal of molecular sciences, 2019, Mar-28, Volume: 20, Issue:7

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Contrast Media; Female; Fluorescent Dyes; Humans; Mice; Microwaves; Nanoparticles; Optical Imaging; Platinum; Porosity; Silicon Dioxide; Tomography, X-Ray Computed

2019
Pursuing Specific Chemotherapy of Orthotopic Breast Cancer with Lung Metastasis from Docking Nanoparticles Driven by Bioinspired Exosomes.
    Nano letters, 2019, 05-08, Volume: 19, Issue:5

    Topics: Animals; Breast Neoplasms; Drug Delivery Systems; Exosomes; Female; Humans; Laurates; Lung Neoplasms; Mice; Nanoparticles; Platinum; Prodrugs; RAW 264.7 Cells; Serum Albumin, Human

2019
EZH2 Is Overexpressed in
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-15, Volume: 25, Issue:14

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Mammary Neoplasms, Animal; Mice; Mice, Knockout; Platinum; Survival Rate; Treatment Outcome

2019
A Triangular Platinum(II) Multinuclear Complex with Cytotoxicity Towards Breast Cancer Stem Cells.
    Angewandte Chemie (International ed. in English), 2019, 08-26, Volume: 58, Issue:35

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cadherins; Carboplatin; Caspases; Cell Line, Tumor; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Female; Humans; Molecular Conformation; Neoplastic Stem Cells; Platinum; Pyrans; RNA Interference; RNA, Small Interfering

2019
Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 08-28, Volume: 308

    Topics: Animals; Antigens, Neoplasm; B7-H1 Antigen; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Female; Gold; Humans; Immunotherapy; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Peptides; Phototherapy; Platinum

2019
Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells.
    Nanoscale, 2019, Aug-15, Volume: 11, Issue:32

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Drug Synergism; Female; Hemolysis; Humans; MCF-7 Cells; Metal Nanoparticles; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Phototherapy; Platinum; Polysaccharides; Signal Transduction; Tomography, X-Ray Computed

2019
Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer.
    Chemical communications (Cambridge, England), 2013, Mar-25, Volume: 49, Issue:24

    Topics: Acridines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA; Drug Design; Female; Humans; Intercalating Agents; MCF-7 Cells; Platinum; Receptors, Estrogen; Tamoxifen

2013
Norspermidine and novel Pd(II) and Pt(II) polynuclear complexes of norspermidine as potential antineoplastic agents against breast cancer.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Female; Humans; Ornithine Decarboxylase; Palladium; Platinum; Spermidine

2013
A highly efficient colorimetric immunoassay using a nanocomposite entrapping magnetic and platinum nanoparticles in ordered mesoporous carbon.
    Advanced healthcare materials, 2014, Volume: 3, Issue:1

    Topics: Antibodies; Biocompatible Materials; Breast Neoplasms; Carbon; Colorimetry; Female; Ferrosoferric Oxide; Humans; Immunoassay; Magnetite Nanoparticles; MCF-7 Cells; Metal Nanoparticles; Nanocomposites; Platinum; Porosity; Receptor, ErbB-2; Rotavirus; Temperature; Time Factors

2014
An aptasensor for sensitive detection of human breast cancer cells by using porous GO/Au composites and porous PtFe alloy as effective sensing platform and signal amplification labels.
    Analytica chimica acta, 2013, Oct-10, Volume: 798

    Topics: Alloys; Aptamers, Nucleotide; Biosensing Techniques; Breast Neoplasms; Electrochemical Techniques; Electrodes; Female; Gold; Graphite; Humans; Iron; MCF-7 Cells; Mucin-1; Nanocomposites; Nanopores; Oxides; Phenothiazines; Platinum; Porosity; Surface Properties

2013
Highly efficient colorimetric detection of target cancer cells utilizing superior catalytic activity of graphene oxide-magnetic-platinum nanohybrids.
    Nanoscale, 2014, Volume: 6, Issue:3

    Topics: Benzidines; Breast Neoplasms; Catalysis; Colorimetry; Female; Graphite; Humans; Immunoassay; Kinetics; Magnetics; Metal Nanoparticles; Microscopy, Electron, Scanning Transmission; Nanotechnology; Oxides; Peroxidase; Peroxidases; Platinum; Sensitivity and Specificity; X-Ray Diffraction

2014
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture.
    British journal of pharmacology, 2014, Volume: 171, Issue:22

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Survival; Cells, Cultured; Cisplatin; Epithelial Cells; Female; Humans; Membrane Potential, Mitochondrial; Organoplatinum Compounds; Platinum; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tumor Cells, Cultured

2014
Electrochemical device based on a Pt nanosphere-paper working electrode for in situ and real-time determination of the flux of H2O2 releasing from SK-BR-3 cancer cells.
    Chemical communications (Cambridge, England), 2014, Sep-14, Volume: 50, Issue:71

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Electrochemical Techniques; Electrodes; Female; Humans; Hydrogen Peroxide; Nanospheres; Paper; Platinum

2014
Cytotoxic response of platinum-coated gold nanorods in human breast cancer cells at very low exposure levels.
    Environmental toxicology, 2016, Volume: 31, Issue:11

    Topics: Acetylcysteine; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 9; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Gold; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Nanotubes; Particle Size; Platinum; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Messenger; Up-Regulation

2016
A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
    Chemistry (Weinheim an der Bergstrasse, Germany), 2015, Jun-15, Volume: 21, Issue:25

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cisplatin; Coordination Complexes; Cytostatic Agents; DNA; Female; Humans; Ligands; Magnetic Resonance Spectroscopy; Platinum; Ruthenium

2015
Structure Effect of Some New Anticancer Pt(II) Complexes of Amino Acid Derivatives with Small Branched or Linear Hydrocarbon Chains on Their DNA Interaction.
    Chemical biology & drug design, 2016, Volume: 88, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; DNA; Drug Screening Assays, Antitumor; Female; Humans; Models, Chemical; Organometallic Compounds; Platinum

2016
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Anti-cancer agents in medicinal chemistry, 2016, Volume: 16, Issue:3

    Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimethylformamide; DNA; Drug Resistance, Neoplasm; Epithelial Cells; Female; Humans; Intercalating Agents; Male; MCF-7 Cells; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Prostatic Neoplasms; Spectrophotometry

2016
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    JAMA neurology, 2016, 07-01, Volume: 73, Issue:7

    Topics: Accidental Falls; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Chi-Square Distribution; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Ovarian Neoplasms; Peripheral Nervous System Diseases; Platinum; Prospective Studies; Severity of Illness Index; Taxoids

2016
A versatile quantitation platform based on platinum nanoparticles incorporated volumetric bar-chart chip for highly sensitive assays.
    Biosensors & bioelectronics, 2016, Nov-15, Volume: 85

    Topics: Breast; Breast Neoplasms; Carcinoembryonic Antigen; Cell Line, Tumor; DNA, Viral; Ebolavirus; Equipment Design; Female; Hemorrhagic Fever, Ebola; Humans; Lab-On-A-Chip Devices; Limit of Detection; Metal Nanoparticles; Platinum; Point-of-Care Systems; Receptor, ErbB-2

2016
RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance.
    The Journal of clinical investigation, 2016, 08-01, Volume: 126, Issue:8

    Topics: Animals; Antibodies, Monoclonal; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cisplatin; CRISPR-Cas Systems; Drug Resistance, Neoplasm; Exons; Female; Germ-Line Mutation; Humans; Mice; Mice, Inbred NOD; Mutation; Neoplasm Transplantation; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Domains

2016
Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent.
    Journal of inorganic biochemistry, 2016, Volume: 165

    Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Hyperthermia, Induced; Nanotubes, Carbon; Phototherapy; Platinum

2016
PARP inhibitor and platinum agent in triple negative breast cancer: utilizing innovative trial design to bring together something "new" and something "old".
    Chinese clinical oncology, 2017, Volume: 6, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Humans; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Triple Negative Breast Neoplasms

2017
Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Steroids, 2008, Volume: 73, Issue:11

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Molecular Structure; Organoplatinum Compounds; Platinum; Spectrophotometry, Infrared; Structure-Activity Relationship

2008
Novel dinuclear platinum(II) complexes targets NFkappaB signaling pathway to induce apoptosis and inhibit metabolism of MCF-7 breast cancer cells.
    Folia histochemica et cytobiologica, 2009, Volume: 47, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Humans; MCF-7 Cells; NF-kappa B; Organoplatinum Compounds; Platinum; Signal Transduction

2009
Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2010, Volume: 26, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; DNA Adducts; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Hyperthermia, Induced; Organoplatinum Compounds; Oxaliplatin; Platinum; Rats; Rats, Inbred F344; Treatment Outcome

2010
Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
    Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Fatal Outcome; Female; Genes, BRCA1; Heterozygote; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Platinum

2012
Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.
    Journal of inorganic biochemistry, 2012, Volume: 115

    Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cytotoxins; Female; Humans; Lung Neoplasms; Platinum; Pyrimidines; Structure-Activity Relationship; X-Ray Diffraction

2012
Choices--and uncertainties--for women with BRCA mutations.
    Science (New York, N.Y.), 2003, Oct-24, Volume: 302, Issue:5645

    Topics: Antineoplastic Agents; Breast Neoplasms; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Heterozygote; Humans; Mastectomy; Mutation; Ovarian Neoplasms; Ovariectomy; Platinum; Risk Assessment; Tamoxifen

2003
A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468.
    Bioorganic & medicinal chemistry letters, 2007, Apr-15, Volume: 17, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cattle; Cell Line, Tumor; Computer Simulation; Cyclin-Dependent Kinase Inhibitor p21; Drug Screening Assays, Antitumor; Female; G1 Phase; Humans; Organometallic Compounds; Platinum; Protein Binding; Structure-Activity Relationship; Superoxide Dismutase; Superoxide Dismutase-1; Triazines; Tumor Suppressor Protein p53

2007
Clinical trials in cancer medicine.
    Australian family physician, 1980, Volume: 9, Issue:1

    Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms

1980
The role of WR-2721 in radiotherapy and/or chemotherapy.
    Cancer clinical trials, 1980,Fall, Volume: 3, Issue:3

    Topics: Alkylating Agents; Amifostine; Animals; Breast Neoplasms; Cyclophosphamide; Humans; In Vitro Techniques; Mechlorethamine; Melphalan; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Organothiophosphorus Compounds; Platinum; Rabbits; Radiation-Protective Agents; Rats; Time Factors

1980
[The protective effects of two hydration protocols against cisplatin nephrotoxicity].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1994, Volume: 16, Issue:1

    Topics: Adult; Breast Neoplasms; Cisplatin; Female; Furosemide; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Platinum

1994
Platinum (II) and (IV) spermidine complexes. Synthesis, characterization, and biological studies.
    Journal of inorganic biochemistry, 1994, Feb-15, Volume: 53, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Circular Dichroism; DNA; Electrophoresis, Agar Gel; Escherichia coli; Female; Humans; Leukemia; Molecular Structure; Organoplatinum Compounds; Plasmids; Platinum; Spectrophotometry, Ultraviolet; Spermidine; Tumor Cells, Cultured

1994
Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
    Anti-cancer drugs, 1997, Volume: 8, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Colonic Neoplasms; DNA, Neoplasm; Enzyme Inhibitors; Female; Fluorouracil; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Thymidylate Synthase; Tumor Cells, Cultured

1997
Placement of endovascular embolization microcoils to localize the site of breast lesions removed at stereotactic core biopsy.
    Radiology, 1998, Volume: 206, Issue:1

    Topics: Biopsy, Needle; Breast; Breast Diseases; Breast Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Platinum; Radiography; Stereotaxic Techniques

1998
Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1- dicarboxylato]platinum(II), a novel, highly active carboplatin derivative.
    Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:11

    Topics: Breast Neoplasms; Carboplatin; Cell Size; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Drug Stability; Female; Humans; Magnetic Resonance Spectroscopy; Ovarian Neoplasms; Platinum; Serum Albumin; Solubility; Tumor Cells, Cultured

1998
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
    Anti-cancer drugs, 2001, Volume: 12, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Hypertension; Hypocalcemia; Hypotension; Infusions, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Paclitaxel; Pancreatic Neoplasms; Platinum; Prednisone; Premedication; Retrospective Studies; Vincristine

2001
Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells.
    Inorganic chemistry, 2001, Jul-30, Volume: 40, Issue:16

    Topics: Biological Transport; Breast Neoplasms; Catalysis; Dimethyl Sulfoxide; Endoplasmic Reticulum; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Organometallic Compounds; Platinum; Pyridines; Receptors, Estrogen; Rhenium; Stereoisomerism; Tumor Cells, Cultured

2001
Kinetics of cis-dichlorodiammineplatinum.
    Clinical pharmacology and therapeutics, 1979, Volume: 25, Issue:3

    Topics: Animals; Blood Proteins; Breast Neoplasms; Cell Survival; Cisplatin; Female; Humans; In Vitro Techniques; Kinetics; Leukemia L1210; Mice; Ovarian Neoplasms; Platinum; Protein Binding

1979
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:2

    Topics: Breast Neoplasms; Cisplatin; Culture Media; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Stability; Humans; Kinetics; Organoplatinum Compounds; Platinum; Stereoisomerism; Time Factors; Tumor Cells, Cultured

1992
[Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1992, Volume: 14, Issue:2

    Topics: Acetylglucosaminidase; Adult; Albuminuria; Breast Neoplasms; Cisplatin; Female; Humans; Immunoglobulin G; Kidney; Middle Aged; Platinum

1992
[Pharmakinetics of carboplatin in cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1991, Volume: 13, Issue:2

    Topics: Adult; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Platinum

1991
Interstitial hyperthermia of malignant brain tumors by implant heating system: clinical experience.
    Journal of neuro-oncology, 1991, Volume: 10, Issue:2

    Topics: Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Equipment Design; Glioblastoma; Glioma; Humans; Hyperthermia, Induced; Iron; Microwaves; Necrosis; Platinum; Prostheses and Implants; Stereotaxic Techniques

1991
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
    International journal of cancer, 1991, Jan-21, Volume: 47, Issue:2

    Topics: Adenocarcinoma; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; DNA; Drug Resistance; Glutathione Transferase; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured

1991
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
    Cancer investigation, 1990, Volume: 8, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction

1990
Cerebrospinal fluid content of manganese, platinum, and strontium in patients with cerebral tumors, leukemia, and other noncerebral neoplasms.
    Oncology, 1990, Volume: 47, Issue:5

    Topics: Adolescent; Adult; Brain Neoplasms; Breast Neoplasms; Female; Humans; Lymphoma; Male; Manganese; Platinum; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reference Values; Sarcoma; Strontium

1990
[The use of direct current in the local destruction of cancer tissues].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Adult; Aged; Animals; Bleomycin; Breast Neoplasms; Dogs; Electric Stimulation Therapy; Electrodes; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Necrosis; Platinum; Tissue Distribution

1989
Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:3

    Topics: Breast Neoplasms; Cisplatin; Female; Head and Neck Neoplasms; Humans; Kinetics; Platinum; Uterine Cervical Neoplasms

1985
Some preliminary observations during the phase I clinical testing of cis-dichlorodiammineplatinum. II.
    Neoplasma, 1973, Volume: 20, Issue:2

    Topics: Adult; Amines; Breast Neoplasms; Carcinoma, Bronchogenic; Chlorides; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Platinum; Stomach Neoplasms

1973